by Bill Malloy | Aug 8, 2022 | Uncategorized
Researchers at the Spanish National Cancer Research Centre (CNIO) have made a pair of discoveries that could potentially improve the treatment of metastatic brain cancers. In a study led by Dr. Manuel Valiente, the team of researchers found a new biomarker that could...
by Bill Malloy | Aug 5, 2022 | Uncategorized
Cancer researchers at Rice University recently conducted a study on how a novel method of anti-cancer medication administration would affect tumors in mice. This exciting new study showed that the potential new treatment method effectively eradicated tumors in a...
by Bill Malloy | Jul 13, 2022 | Uncategorized
A study recently published in the journal of European Urology Oncology has found a link between microbiomes in the urine and the development of several forms of cancer, especially advanced prostate cancer. The findings of this study suggest that five different types...
by Bill Malloy | Jul 5, 2022 | Uncategorized
A recent study at Sweden’s Karolinska Institute has revealed that a protein called GIT1 has shown the ability to protect against the growth of estrogen receptor-negative breast tumors. This type of breast cancer is among the most difficult variations to treat, and the...
by Bill Malloy | Jun 29, 2022 | Uncategorized
A clinical trial at the University of Cincinnati has found that adding a newly developed immunotherapy drug to standard treatment methods could improve survival rates for head and neck cancer patients. The trial was led by Trisha Wise-Draper, MD, and published in the...
by Bill Malloy | Jun 13, 2022 | Uncategorized
An international study researching innovations in the treatment of colorectal cancer was bolstered in early February by a five-year renewal and $10 million in new funding. Based at the Huntsman Cancer Institute at the University of Utah, the ColoCare Study commenced...
